Ondine Biomedical, Inc.'s total assets for Q4 2023 were C$5.73M, a decrease of -22.58% from the previous quarter. GB:OBI total liabilities were C$3.65M for the fiscal quarter, a 11.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.